 NEWARK, N.J., Sept. 14, 2021 PRNewswire -- Rafael Holdings, Inc., NYSE: RFL, a pharmaceutical holding company focused on developing novel cancer metabolism therapeutics through its Barer Institute and investment in Rafael Pharmaceuticals, Inc., announced today the appointment of Patrick Fabbio as Chief Financial Officer. 